Trial
NCT02174094
Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Dravet Syndrome
Intervention
Clobazam
Why stopped
The study was terminated due to recruitment challenges
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-24